Medical professionals should carefully study the merits of smoke-free products as alternatives to combustible cigarettes, according to an official of the U.S. Food and Drug Administration Center for Tobacco Products (FDA-CTP).
A commentary co-authored by Dr. Brian King, director of the FDA-CTP, and published by Nature Medicine, a peer-reviewed medical journal, discusses the considerations healthcare providers have for talking to adults about the relative risks of different tobacco products.
The commentary...
The IT and Business Process Association of the Philippines expressed confidence on the validity of the letters of authority issued by the Philippine Economic...
More countries in Southeast Asia are considering tobacco harm reduction as state policy, looking at regulating smoke-free alternatives to cigarettes to address the smoking...